Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D004343:Drug Implants; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D010349:Patient Compliance; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D004343:Drug Implants; D005476:Fluphenazine